Gonorrhoea (Neisseria Gonorrhoea) CEG (961)

A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments.

Clinical judgement should be exercised on the applicability of any guideline, influenced by individual patient characteristics. Clinicians should be mindful of the potential for harmful polypharmacy and increased susceptibility to adverse drug reactions in patients with multiple morbidities or frailty.

If, after discussion with the patient or carer, there are good reasons for not following a guideline, it is good practice to record these and communicate them to others involved in the care of the patient.

Resources

Use the button below to access this item.

Access this resource

Editorial Information

Last reviewed: 11/07/2024

Next review date: 30/09/2025

Author(s): Kay McAllister.

Version: 4

Author email(s): kay.mcallister2@nhs.scot.

Approved By: Sandyford Governance Group

Reviewer name(s): Kay McAllister.

Document Id: 961

References

Gonorrhoea management:
British Association for Sexual Health and HIV Clinical Effectiveness Group. (2018).
2018 UK National Guideline for management of infection with Neisseria gonorrhoeae.
Available at https://www.bashh.org/resources/14/gonorrhoea_2018 [accessed online 08/02/2024]

Gonorrhoea antibiotic resistance:
Public Health Scotland. Gonorrhoea infection in Scotland - Gonorrhoea infection in Scotland - Publications - Public Health Scotland [accessed 08/02/2024]

GRASP report: data to June 2023 .Available at
https://www.gov.uk/government/publications/gonococcal-resistance-to-antimicrobials-surveillance-programme-grasp-report/grasp-report-data-to-june-2023 [accessed 08/02/2024]

Genital meningococcal disease
Ladhani SN et al. Meningococcal disease and sexual transmission: urogenital and
anorectal infections and invasive disease due to Neisseria meningitidis. Lancet (2020)
395:1865-1877 Available at
https://www.sciencedirect.com/science/article/abs/pii/S0140673620309132 [accessed 08/02/2024]

Medicines information:
Medicines and Healthcare products Regulatory Agency. Fluoroquinolone antibiotics:
must now only be prescribed when other commonly recommended antibiotics are
inappropriate alerts about fluoroquinolone. 22/1/2024. Available at
https://www.gov.uk/drug-safety-update/fluoroquinolone-antibiotics-must-now-only-be-prescribed-when-other-commonly-recommended-antibiotics-are-inappropriate [accessed 08/02/2024]

Spectinomycin manufacturer’s instructions:
https://www.bashh.org/documents/Spectinomycin%20leaflet.pdf  [accessed 08/02/2024]

Summary of Product Characteristics Ceftriaxone 1g powder for injection
https://www.medicines.org.uk/emc/product/1361/smpc [accessed 08/02/2024]

Summary of Product Characteristics Gentamicin 40mgs/ml injection. Gentamicin 40mg/ml Solution for Injection or Infusion - Summary of Product Characteristics (SmPC) - (emc) (medicines.org.uk) [accessed 08/02/2024]